Investor Presentation has been updated on their website.
CAR-T stuff on their now. Pursuing a partnership, but we already knew that. Plus 3 new immunotherapies that Pelareorep may work to enhance. 1. Bispecific Antibodies ( This is reallly interesting, more on this later researching) 2. PARP inhibitors. 3. CDK4/6 inhibitors. Cheers!